Organoidsciences Ltd. (KOSDAQ:476040)
27,200
+950 (3.62%)
At close: Mar 20, 2026
Organoidsciences Market Cap
Organoidsciences has a market cap or net worth of 179.13 billion as of March 20, 2026.
Market Cap
179.13B
Enterprise Value
164.07B
Revenue
2.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
27,200.00
Market Cap Chart
Since May 9, 2025, Organoidsciences's market cap has decreased from 208.19B to 179.13B, a decrease of -13.96%. That is a compound annual growth rate of -15.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 179.13B | -28.92% |
| Dec 30, 2025 | 252.02B | 21.05% |
| May 9, 2025 | 208.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NOVAREX | 237.74B |
| OPTUS Pharmaceutical | 184.23B |
| GREEN CROSS WellBeing | 182.42B |
| Vivozon Pharmaceutical | 170.70B |
| High Tech Pharm | 169.07B |
| Kyung Dong Pharmaceutical | 147.37B |
| Pharos iBio | 145.51B |
| DongKoo Bio & Pharma | 141.97B |